- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
The issue of adulterants in cannabis vape products has once again resurfaced as the Pennsylvania Office of Medical Marijuana issued a notice to medical cannabis patients on February 4, 2022 advising them of a recall of over 500 different products containing substances not suitable for inhalation. The problem was first brought to light when the VAPI (vaping associated pulmonary injury) crisis occurred in 2019, which sickened over 2,800 people and killed at least 68. The source of the outbreak was linked to the use of Vitamin E acetate and other diluents that are more likely to be found in illicit market vapes than legal market products.
Pennsylvania is not the only state to conduct recalls of vaping products though. In 2020, Oregon asked retailers to voluntarily recall vape products containing squalene and squalane, chemicals that were also linked to the VAPI crisis and Michigan issued a recall of almost 10,000 vape products over concerns of Vitamin E acetate use.
The extraction process, designed to get the cannabinoids out of the flower and into a concentrated form, oftentimes strips other materials away, some of them not needed like fats and chlorophyll, but some, like the terpenes, are needed as they have properties that both aid in the medical benefit of cannabis and also provide the taste and smell that cannabis is known for. In order to put the taste and smell back into a product, terpenes may be added back into the concentrate, however some of the terpenes may be synthetic and break down into potentially dangerous substances when vaporized and inhaled into the lungs.
In response to this issue, many states have put bans on the use of Vitamin E acetate, squalene, squalane, and other related substances. This doesn’t stop the illicit market from using these substances though and purchasers should utilize the legal cannabis market where products are more likely to be tested and labeled.
Join us for a free webinar on March 15, 2022 at 3pm EST/12pm PST as we discuss cannabis adulterants and how you can watch out for potentially harmful products.